MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 03-03-2026
Agilent Technologies ROA Ratio 2011-2026 | A
Annual ROA Ratio Agilent Technologies
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 11.3 | 7.47 | 11.33 | 3.7 | 8.12 | 5.92 | 5.36 | 4.65 | 6.78 | 10.94 | 11.17 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 11.33 | 3.7 | 7.89 |
Quarterly ROA Ratio Agilent Technologies
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.55 | 5.42 | 5.42 | 5.47 | 5.6 | 8.34 | 5.54 | 8.16 | 7.98 | 8.22 | 8.11 | 10.63 | 10.03 | 6.61 | 11.77 | 11.32 | 10.37 | 13.93 | 18.04 | 18.0 | 18.85 | 9.55 | 1.68 | 2.42 | 2.89 | 8.7 | 13.3 | 12.62 | 12.17 | 11.7 | 9.99 | 9.51 | 8.73 | 7.91 | 7.09 | 6.98 | 6.98 | 7.97 | 8.93 | 8.8 | 8.92 | 8.77 | 9.12 | 9.34 | 9.61 | 10.45 | 12.56 | 13.3 | 14.16 | 14.04 | 15.11 | 16.45 | 16.23 | 7.98 | 3.64 | 2.21 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 18.85 | 1.68 | 9.61 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Burning Rock Biotech Limited
BNR
|
-34.96 | $ 16.2 | -0.61 % | $ 175 M |  China |
 |
Aspira Women's Health
AWH
|
-234.24 | - | -6.19 % | $ 10.5 M |  USA |
|
Biodesix
BDSX
|
-44.15 | $ 15.07 | 2.1 % | $ 1.95 B | USA |
 |
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | USA |
 |
Co-Diagnostics
CODX
|
-189.54 | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-6670.82 | - | - | $ 9.42 M |  Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M |  Britain |
 |
Castle Biosciences
CSTL
|
3.43 | $ 24.84 | -0.84 % | $ 690 M | USA |
 |
BioNano Genomics
BNGO
|
-35.87 | $ 1.2 | 0.84 % | $ 6.53 M | USA |
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Charles River Laboratories International
CRL
|
-2.02 | $ 173.89 | -0.58 % | $ 8.62 B | USA |
 |
DarioHealth Corp.
DRIO
|
-37.9 | $ 8.4 | 3.7 % | $ 33.5 M | Israel |
 |
Accelerate Diagnostics
AXDX
|
-22.47 | - | -61.36 % | $ 2.46 M | USA |
 |
DexCom
DXCM
|
13.19 | $ 62.22 | -0.24 % | $ 24.3 B | USA |
 |
Biomerica
BMRA
|
-83.65 | $ 2.17 | -0.91 % | $ 4.98 M | USA |
 |
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M | China |
 |
Celcuity
CELC
|
-37.95 | $ 112.63 | -0.27 % | $ 5.27 B | USA |
 |
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | China |
 |
Exact Sciences Corporation
EXAS
|
-3.55 | - | - | $ 19.8 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | USA |
 |
Fulgent Genetics
FLGT
|
-3.5 | $ 16.82 | 2.31 % | $ 509 M | USA |
 |
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
6.11 | $ 198.02 | 0.17 % | $ 22 B | USA |
 |
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | USA |
 |
Guardant Health
GH
|
-20.67 | $ 93.83 | 2.94 % | $ 11.8 B | USA |
 |
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 114.19 | 2.49 % | $ 9.42 B |  Irlanda |
 |
Interpace Biosciences
IDXG
|
72.63 | $ 1.96 | 5.82 % | $ 8.67 M | USA |
 |
IDEXX Laboratories
IDXX
|
31.62 | $ 569.55 | 0.87 % | $ 45.8 B | USA |
 |
IQVIA Holdings
IQV
|
4.54 | $ 173.26 | 0.5 % | $ 29.8 B | USA |
 |
Illumina
ILMN
|
-19.4 | $ 127.38 | 0.59 % | $ 20.3 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
10.73 | $ 27.11 | -0.66 % | $ 20 B |  Niderland |
 |
QIAGEN N.V.
QGEN
|
6.76 | - | - | $ 10.6 B | Niderland |
 |
Lantheus Holdings
LNTH
|
10.49 | $ 76.1 | 0.53 % | $ 5.14 B | USA |
 |
Medpace Holdings
MEDP
|
22.84 | $ 498.34 | 1.81 % | $ 14.4 B | USA |
 |
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
4.77 | $ 273.72 | 0.36 % | $ 22.8 B | USA |
 |
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K | Israel |
 |
Sotera Health Company
SHC
|
2.39 | $ 14.96 | 0.61 % | $ 4.25 B | USA |
 |
Mettler-Toledo International
MTD
|
23.41 | $ 1 259.94 | -1.11 % | $ 26 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
-51.78 | $ 4.75 | 3.49 % | $ 440 M | USA |
 |
NeoGenomics
NEO
|
-7.94 | $ 8.0 | 3.23 % | $ 1.02 B | USA |
 |
Neogen Corporation
NEOG
|
-31.71 | $ 9.41 | 0.21 % | $ 2.04 B | USA |
 |
CareDx, Inc
CDNA
|
-5.17 | $ 18.31 | 2.46 % | $ 976 M | USA |
 |
National Research Corporation
NRC
|
8.6 | $ 17.16 | -1.04 % | $ 384 M | USA |